127 related articles for article (PubMed ID: 34693928)
1. Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.
Bautista-Martínez JS; Mata-Marín JA; Sandoval-Ramírez JL; Chaparro-Sánchez A; Manjarrez-Téllez B; Uribe-Noguez LA; Gaytán-Martínez J; Núñez-Armendáriz M; Cruz-Sánchez A; Núñez-Rodríguez N; Iván MA; Morales-González GS; Álvarez-Mendoza JP; Pérez-Barragán E; Ríos-De Los Ríos J; Contreras-Chávez GG; Tapia-Magallanes DM; Ribas-Aparicio RM; Díaz-López M; Olivares-Labastida A; Gómez-Delgado A; Torres J; Miranda-Duarte A; Zenteno JC; Pompa-Mera EN
Pharmacogenet Genomics; 2022 Apr; 32(3):101-110. PubMed ID: 34693928
[TBL] [Abstract][Full Text] [Related]
2. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Arnedo M; Taffé P; Sahli R; Furrer H; Hirschel B; Elzi L; Weber R; Vernazza P; Bernasconi E; Darioli R; Bergmann S; Beckmann JS; Telenti A; Tarr PE;
Pharmacogenet Genomics; 2007 Sep; 17(9):755-64. PubMed ID: 17700364
[TBL] [Abstract][Full Text] [Related]
3. The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis.
Au A; Griffiths LR; Irene L; Kooi CW; Wei LK
Atherosclerosis; 2017 Oct; 265():60-70. PubMed ID: 28865324
[TBL] [Abstract][Full Text] [Related]
4. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
5. Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.
Cabello I; Alia P; Pintó X; Muniesa C; Fernandez-de-Misa R; Peñate Y; Morillo M; Perez-Farriols A; Estrach T; Izu R; Gallardo F; Román C; Cervigón I; Ortiz-Brugues A; Ortiz-Romero PL; Servitje O
JAMA Dermatol; 2018 Dec; 154(12):1424-1431. PubMed ID: 30422238
[TBL] [Abstract][Full Text] [Related]
6. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; de Bakker PI; Asselbergs FW; Spiering W; Visseren FL;
PLoS One; 2014; 9(6):e101082. PubMed ID: 24979386
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.
Obirikorang C; Acheampong E; Quaye L; Yorke J; Amos-Abanyie EK; Akyaw PA; Anto EO; Bani SB; Asamoah EA; Batu EN
PLoS One; 2020; 15(1):e0227779. PubMed ID: 31929604
[TBL] [Abstract][Full Text] [Related]
8. Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
Taşkin E; Bağci H; Turan MK
Rev Assoc Med Bras (1992); 2023; 69(3):415-420. PubMed ID: 36921196
[TBL] [Abstract][Full Text] [Related]
9.
Srinivasan R; Padmapriyadarsini C; Ramesh K; Sanjeeva GN; Reddy D; Suresh E; Kumar R; Sathyamoorthy P; Swaminathan S; Shet A
AIDS Res Hum Retroviruses; 2021 Feb; 37(2):92-100. PubMed ID: 33115242
[TBL] [Abstract][Full Text] [Related]
10. The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population.
Wang Y; Liu F; Li L; Deng S; He Z
J Int Med Res; 2017 Dec; 45(6):2042-2052. PubMed ID: 28635360
[TBL] [Abstract][Full Text] [Related]
11. Association of rs662799 and rs5070 genetic polymorphisms with hypertriglyceridemia and atherogenic dyslipidemia in pediatric patients in Southeast Mexico.
Ovando Gómez V; Zavaleta Muñiz SA; Ochoa-Díaz-López H; Hernández Contreras JAC; Irecta Nájera CA
Clin Investig Arterioscler; 2023; 35(2):53-63. PubMed ID: 35961839
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
13. Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in hiv-infected individuals in Taiwan.
Chang SY; Ko WS; Kao JT; Chang LY; Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SF; Liu WC; Wu CH; Hsu HJ; Kao CL; Lee CN; Hung CC; Chang SC
Clin Infect Dis; 2009 Mar; 48(6):832-5. PubMed ID: 19187029
[TBL] [Abstract][Full Text] [Related]
14. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
15. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children.
Suárez-Sánchez F; Klunder-Klunder M; Valladares-Salgado A; Gómez-Zamudio J; Peralta-Romero J; Meyre D; Burguete-García A; Cruz M
Pediatr Obes; 2017 Aug; 12(4):330-336. PubMed ID: 27171122
[TBL] [Abstract][Full Text] [Related]
16. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE; Taffé P; Bleiber G; Furrer H; Rotger M; Martinez R; Hirschel B; Battegay M; Weber R; Vernazza P; Bernasconi E; Darioli R; Rickenbach M; Ledergerber B; Telenti A;
J Infect Dis; 2005 May; 191(9):1419-26. PubMed ID: 15809899
[TBL] [Abstract][Full Text] [Related]
17. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
18. Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes.
Vrablik M; Hubacek JA; Dlouha D; Satny M; Adamkova V; Ceska R
Folia Biol (Praha); 2019; 65(4):188-194. PubMed ID: 31903892
[TBL] [Abstract][Full Text] [Related]
19. [Geographical characteristics of single nucleotide polymorphism of candidate genes associated with coronary artery disease in Chinese Han population].
Wang SH; Cui HB; Wang DQ; Chen XM; Zhang HK; Cui CC; Chen XY; Liu XH; Zhang Z; Bai F; Jb M
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan; 36(1):24-9. PubMed ID: 19099922
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.
Liu Y; Ordovas JM; Gao G; Province M; Straka RJ; Tsai MY; Lai CQ; Zhang K; Borecki I; Hixson JE; Allison DB; Arnett DK
Pharmacogenet Genomics; 2009 Feb; 19(2):161-9. PubMed ID: 19057464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
